Novo Nordisk founders:
August (1874–1949) and
Marie Krogh (1874–1943)
Together with the obesity community and through collaboration with professional organisations, Novo Nordisk is working to improve access to care and raise awareness of the unmet needs in obesity care.
Novo Nordisk is committed to delivering treatment options, tools and support programs that are the result of listening to and learning from the people with obesity and those who support them.
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.